Genmab A/S (FRA:GE9)
Germany flag Germany · Delayed Price · Currency is EUR
240.00
-2.40 (-0.99%)
At close: Feb 20, 2026

Genmab Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Revenue
3,7203,1212,3902,0841,287
Revenue Growth (YoY)
19.19%30.59%14.68%61.88%-22.52%
Cost of Revenue
23814333--
Gross Profit
3,4822,9782,3572,0841,287
Selling, General & Admin
626549478384.48196.24
Research & Development
1,6061,4141,107799.14639.51
Operating Expenses
2,2321,9631,5851,184835.75
Operating Income
1,2501,015772900.43451.68
Interest Expense
-61-18-10-5.6-1.99
Interest & Investment Income
13814414246.5530.13
Currency Exchange Gain (Loss)
-392-66151.01224.85
EBT Excluding Unusual Items
1,3241,2338381,092704.67
Merger & Restructuring Charges
-185-43---
Gain (Loss) on Sale of Investments
65136-21-94.54-105.39
Pretax Income
1,2041,326817997.85599.28
Income Tax Expense
241193186214.51146.99
Net Income
9631,133631783.33452.29
Net Income to Common
9631,133631783.33452.29
Net Income Growth
-15.00%79.56%-19.45%73.19%-42.16%
Shares Outstanding (Basic)
6264656565
Shares Outstanding (Diluted)
6365666666
Shares Change (YoY)
-3.04%-1.88%-0.17%-0.06%0.24%
EPS (Basic)
15.4917.659.6611.986.92
EPS (Diluted)
15.3717.539.5811.876.85
EPS Growth
-12.32%82.98%-19.27%73.29%-42.30%
Free Cash Flow
1,1491,0991,018516.52302.24
Free Cash Flow Per Share
18.3317.0015.457.834.58
Gross Margin
93.60%95.42%98.62%100.00%100.00%
Operating Margin
33.60%32.52%32.30%43.21%35.08%
Profit Margin
25.89%36.30%26.40%37.59%35.13%
Free Cash Flow Margin
30.89%35.21%42.59%24.79%23.48%
EBITDA
1,2901,052802941.81481.35
EBITDA Margin
34.68%33.71%33.56%45.19%37.39%
D&A For EBITDA
40373041.3829.67
EBIT
1,2501,015772900.43451.68
EBIT Margin
33.60%32.52%32.30%43.21%35.08%
Effective Tax Rate
20.02%14.56%22.77%21.50%24.53%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.